By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS








Company News
Data On Immunology Effects Of Provectus Biopharmaceuticals Inc. PV-10 In Colon Cancer Presented At 11th Annual ASC Meeting 2/3/2016 12:11:19 PM
Provectus Biopharmaceuticals Inc. To Present At 18th Annual BIO CEO & Investor Conference 2/2/2016 11:22:30 AM
Provectus Biopharmaceuticals Inc. Announces Immunology Data On PV-10 In Colon Cancer To Be Presented At 11th Annual ASC Meeting 1/22/2016 6:51:22 AM
Provectus Biopharmaceuticals Inc. Confirms First Patients Dosed In Trials Of PV-10 For Melanoma 1/12/2016 12:02:47 PM
Provectus Biopharmaceuticals Inc. To Present At Biotech Showcase 2016 On Wednesday January 13, 2016 At 3:30 PM Pacific Time 12/16/2015 10:22:45 AM
Provectus Biopharmaceuticals Inc. Reports Immune Mechanism Of Action Data For Pv-10 Presented At Society For Immunotherapy Of Cancer Annual Meeting Authored By Researchers At Moffitt Cancer Center 11/6/2015 12:02:53 PM
Provectus Biopharmaceuticals Inc. Reports Third Quarter 2015 Financial Results 11/5/2015 11:40:54 AM
Provectus Biopharmaceuticals Inc. Will Hold Its 2015 Third Quarter Business Update Conference Call On Thursday, November 5, 2015, At 5 PM Eastern Standard Time 10/20/2015 10:24:12 AM
Provectus Biopharmaceuticals Inc. Reports Publication Of Review Paper On PV-10 Tumor Ablation And Immune Stimulation 9/29/2015 11:18:49 AM
Provectus Biopharmaceuticals Inc. Announces Initiation Of Phase Ib/II Clinical Trial To Study PV-10 In Combination With Immune Check Point Inhibitor Pembrolizumab 9/23/2015 11:15:37 AM
12345678910...
//-->